Advocacy Actions
Meeting with ASOP on Safety of Online Pharmacies in China
The European Chamber held a meeting with a delegation of the Alliance for Safe Online Pharmacies (ASOP Global) on Safety of Online Pharmacies.
Read moreMeeting on the Horizon 2020 Work Programme 2018-2020
On 29th November, 2017, the European Chamber had the pleasure to welcome Dr. Laurent Bochereau, Head of Science, Technology and Environment Section, EU Delegation to China to our joint Working Group meeting on Horizon 2020. Mr Bochereau presented the recently released Horizon 2020 Work Programme 2018-2020 and share his insights on cooperation opportunities for industries, followed by a Q&A session with the members.
Read moreMeeting with Prof. Hu Shanlian on Position Paper and Health Insurance Policy
European Chamber Pharmaceutical Working Group GA Coordinator met with Prof. Hu Shanlian, Senior Consultant of Shanghai Health Development Research Center
Read moreComments on CFDA's Administrative Measures of Drug Registration
Pharmaceutical Working Group comments on CFDA's Administrative Measures of Drug Registration
Read moreComments on SCLAO's Amendment of the Drug Administration Law of PRC (Draft for Comments)
Pharmaceutical Working Group Comments on SCLAO's Amendment of the Drug Administration Law of PRC (Draft for Comments)
Read moreComments on Shanghai FDA's Trial Administrative Measures on Medical Representative Registration
Comments on Shanghai FDA's Trial Administrative Measures on Medical Representative Registration
Read moreComments to NPC on Anti-Unfair Competition Law (Second Draft for Review)
On September 22, 2017, the European Chamber submitted feedback received from members regarding the call for comments on the second review draft of revision on Anti-Unfair Competition Law issued by the National People’s Congress (NPC).
Read moreComments on CDE's Catalogue of Marketed Drugs in China (Draft for Comments)
European Chamber Pharmaceutical Working Group comments on CDE's Catalogue of Marketed Drugs in China (Draft for Comments)
Read moreComments on CFDA's Announcement on Relevant Issues on Generics Quality and Efficacy Consistency Evaluation
European Chamber Comments on CFDA's Announcement on Relevant Issues on Generics Quality and Efficacy Consistency Evaluation
Read moreComments on CFDA's Inspection Guidelines on Generics Quality and Efficacy Consistency Evaluation
European Chamber Comments on CFDA's Inspection Guidelines on Generics Quality and Efficacy Consistency Evaluation
Read more